Camp4 Therapeutics Cash Flow Statement (2023-2025) | CAMP

Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -11.70M-12.99M-12.48M-12.43M-13.48M-13.28M-12.51M-12.57M-13.23M
Share-based Compensation 0.72M0.64M0.86M0.79M1.59M0.80M0.86M1.00M0.98M
Gains from Sales and Divestitures 0.04M
Gains from Investment Securities 0.09M0.09M2.08M0.10M0.07M0.22M-0.20M
Asset Writedowns and Impairment 0.49M
Non-cash Items 10.35M
Cash from Operations -11.78M-11.14M-13.44M-9.69M-11.33M-14.30M-10.33M-11.22M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.40M0.43M0.45M0.47M0.48M0.49M
Amortization of Deferred Charges 0.03M0.03M0.02M0.02M0.01M0.11M-0.10M0.00M
Depreciation & Amortization (CF) 0.43M0.44M0.42M0.42M0.42M0.42M0.43M0.42M
Change in Working Capital
Change in Account Payables -0.15M0.98M-1.04M1.08M-0.86M0.17M-0.19M-0.55M
Change in Accured Expenses 0.56M0.45M-1.48M0.72M1.84M-2.79M1.03M1.36M
Investing Activities
Capital Expenditures 0.24M0.15M0.03M0.26M0.28M
Cash from Investing Activities -0.24M-0.01M-0.16M-0.26M-0.28M0.04M
Financing Activities
Other financing activities 0.21M3.16M14.93M
Change in Capital Stock
Shares Issued 0.17M0.00M0.03M76.32M32.56M
Misc.
Cash from Financing Activities -0.06M-0.20M-0.81M-0.39M73.06M-0.15M0.07M47.38M
Change in Cash -12.09M-11.36M-14.41M-10.08M61.51M-14.72M-10.27M36.20M
Free Cash Flow -12.03M-11.29M-13.46M-9.69M-11.59M-14.58M-10.33M-11.22M
Net Cash Flow -12.09M-11.36M-14.41M-10.08M61.47M-14.73M-10.26M36.20M